Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Eya Kalai"'
Autor:
Kahena Bouzid, Habib B. Ahmed, Eya Kalai, Salma Blibeche, Nathalie Couque, Karima Khiari, Afef Bahlous, Jaouida Abdelmoula
Publikováno v:
Libyan Journal of Medicine, Vol 9, Iss 0, Pp 1-5 (2014)
Background: In Tunisia, diabetes mellitus and hemoglobinopathies are major public health problems. Glycated hemoglobin (HbA1c) is recommended for long-term monitoring of diabetes mellitus, but the presence of hemoglobin variants may interfere with Hb
Externí odkaz:
https://doaj.org/article/974a3150baa94f4c873d4a341cb69dd4
Autor:
Asma Krir, Kamel Hamzaoui, Eya Kalai, Wajih Kaabachi, Mouna Bouksila, Mohammed Karim Zouaghi, Elhem Cheour El Kateb, Hela Sahli, W. Smaoui, Sonia Rekik, Afef Bahlous, Mehdi Mrad, Nesrine Issaoui
Publikováno v:
Journal of Medical Biochemistry
Journal of Medical Biochemistry, Vol 38, Iss 4, Pp 418-426 (2019)
Journal of Medical Biochemistry, Vol 38, Iss 4, Pp 418-426 (2019)
Chronic kidney disease (CKD) is associated with numerous complications such as bone mineral disorder. The aim of our study was to analyze the correlation of bone turnover markers with Bone Mineral Density (BMD) measurements in Tunisian end stage rena
Autor:
Mouna Chelly, Jaouida Abdelmoula, Kahena Bouzid, Eya Kalai, Lilia Laadhar, Nadine Charni, Hela Sahli, Bechir Zouari, Sondes Makni, Patrick Garnero, Hatem Rajhi, Slaheddine Sallemi, A. Bahlous
Publikováno v:
Revue du Rhumatisme. 79:418-424
Resume Objectifs La degradation proteolytique de l’agrecane constitue un element cle dans la physiopathologie de l’arthrose. Le but de cette etude a ete de developper un test immunoenzymatique Elisa permettant de quantifier les taux seriques des
Autor:
Kahena Bouzid, Ahmed Achour, A. Bahlous, Jaouida Abdelmoula, M. Hassine, Eya Kalai, F. Ben Mami Ben Miled, H. Ben Ahmed, R. Boujnah
Publikováno v:
Annales de Cardiologie et d'Angéiologie. 61:81-87
Resume Objectif Etudier la frequence de l’ischemie myocardique silencieuse (IMS) chez les diabetiques de type 2 Tunisiens recemment decouverts et identifier les facteurs de risque cardiovasculaire directement lies a l’IMS. Patients et methodes Ce
Autor:
Slaheddine Sellami, Eya Kalai, Mouna Chelly, Jaouida Abdelmoula, Kahena Bouzid, Lilia Laadhar, Elhem Cheour, A. Bahlous, Hela Sahli
Publikováno v:
Annales de biologie clinique. 72(6)
Objectifs : Evaluer l’interet diagnostique et pronostique des marqueurs de degradation du collagene II (CII) au cours de la gonarthrose dans une population tunisienne. Materiel et methodes : 125 femmes gonarthrosiques (54 ± 8 ans) ont ete comparee
Autor:
Karima Khiari, Kahena Bouzid, Eya Kalai, Habib Ben Ahmed, Jaouida Abdelmoula, Nathalie Couque, A. Bahlous, Salma Blibeche
Publikováno v:
Libyan Journal of Medicine; Vol 9 (2014): incl Supplements
Libyan Journal of Medicine; Vol 9, No 1 (2014)
The Libyan Journal of Medicine
Libyan Journal of Medicine, Vol 9, Iss 0, Pp 1-5 (2014)
Libyan Journal of Medicine; Vol 9, No 1 (2014)
The Libyan Journal of Medicine
Libyan Journal of Medicine, Vol 9, Iss 0, Pp 1-5 (2014)
Background : In Tunisia, diabetes mellitus and hemoglobinopathies are major public health problems. Glycated hemoglobin (HbA1c) is recommended for long-term monitoring of diabetes mellitus, but the presence of hemoglobin variants may interfere with H
Autor:
Rolande Ducrocq, Jaouida Abdelmoula, Eya Kalai, Kahena Bouzid, Faika Ben Mami, A. Bahlous, Wafa Ferjani
Publikováno v:
Clinical Laboratory. 59
Autor:
Kahena, Bouzid, Afef, Bahlous, Wafa, Ferjani, Eya, Kalai, Rolande, Ducrocq, Faika, Ben Mami, Jaouida, Abdelmoula
Publikováno v:
Clinical laboratory. 58(7-8)
Several studies demonstrate significant bias in analytical methods used to measure glycohemoglobin. The clinical importance of that fact is evident when HbA1c overestimation leads to aggressive glucose management, resulting in more frequent hypoglyca
Autor:
A. Bahlous, Bechir Zouari, Slaheddine Sallemi, Mouna Chelly, Sondes Makni, Hatem Rajhi, Eya Kalai, Kahena Bouzid, Jaouida Abdelmoula, Patrick Garnero, Lilia Laadhar, Nadine Charni, Hela Sahli
Publikováno v:
Joint bone spine. 79(6)
Proteolytic degradation of aggrecan is a hallmark of the pathology of osteoarthritis. The aim of this study was to develop enzyme-linked immunosorbent assay (ELISA) to quantify the serum levels of specific aggrecan fragments generated by aggrecanases
Publikováno v:
La Tunisie medicale. 84(11)
The recent development of new biochemical markers has considerably improved the non invasive exploration of bone turnover. Currently, the most sensitive markers to access bone formation are osteocalcin, bone alkaline phosphatase and N-terminal propep